MALARIA TRANSMISSION-BLOCKING VACCINE

The present invention relates to malaria vaccines. Particularly, the present invention relates to antigens that are effective to prevent the transmission of malaria. The antigen comprises a fragment of AnAPN1. La présente invention concerne des vaccins contre la malaria. L'invention concerne pl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DINGLASAN, RHOEL, RAMOS, SHAH-BROWN, AMI, ZAHN, BIN, BOTTAZZI, MARIA, ELENA, HOTEZ, PETER, J
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to malaria vaccines. Particularly, the present invention relates to antigens that are effective to prevent the transmission of malaria. The antigen comprises a fragment of AnAPN1. La présente invention concerne des vaccins contre la malaria. L'invention concerne plus particulièrement des antigènes dont l'action permet de prévenir la transmission de la malaria. L'antigène comprend un fragment d'AnAPN1.